Long-term impact of the women's health initiative on HRT

被引:34
作者
Parente, Lynn [5 ]
Uyehara, Catherine [4 ]
Larsen, Wilma [3 ]
Whitcomb, Bradford [2 ]
Farley, John [1 ]
机构
[1] Uniformed Serv Univ Hlth Sci, Dept Obstet & Gynecol, Bethesda, MD 20832 USA
[2] Tripler Army Med Ctr, Dept Obstet & Gynecol, Honolulu, HI 96859 USA
[3] William Beaumont Army Med Ctr, Ft Bliss, TX USA
[4] Tripler Army Med Ctr, Dept Clin Invest, Honolulu, HI 96859 USA
[5] Womack Army Commun Hosp, Dept Obstet & Gynecol, Ft Bragg, NC USA
关键词
WHI; HRT; prescription rate;
D O I
10.1007/s00404-007-0442-1
中图分类号
R71 [妇产科学];
学科分类号
100211 [妇产科学];
摘要
Objective To evaluate the long-term trends in the HRT following the results of the WHI, which were made public in July 2002. Study design An observational cohort study was performed from prescription data of estrogen containing products ordered from Tripler Army Medical Center between July 1999 and July 2005. We used automated pharmacy data to identify all estrogen products dispensed to active duty soldiers, dependent wives, and retirees during the study period. Differences in prescription rate were compared between groups using a Student's t-test. Results A total of 71,592 prescriptions were written for HRT. Prescriptions decreased from 1,272/month at the start of the study to 493/month at the conclusion of the study. Prior to July 2002 OBGYNs were the first to decrease their prescribing rate of estrogen, and this decrease was greater than other specialties analyzed. The frequency of HRT prescriptions decreased after July 2002 while the percentage of patients who filled HRT prescriptions increased from 68 to 72%. Conclusions We have found a significant decrease in prescriptions after release of the WHI initiative results. With this decrease in prescribing rate of HRT we found that a greater percentage of women actually filled their prescriptions perhaps indicating greater certainty in their choice.
引用
收藏
页码:219 / 224
页数:6
相关论文
共 13 条
[1]
Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures - The Women's Health Initiative randomized trial [J].
Anderson, GL ;
Judd, HL ;
Kaunitz, AM ;
Barad, DH ;
Beresford, SAA ;
Pettinger, M ;
Liu, J ;
McNeeley, SG ;
Lopez, AM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (13) :1739-1748
[2]
Effects of conjugated, equine estrogen in postmenopausal women with hysterectomy - The women's health initiative randomized controlled trial [J].
Anderson, GL ;
Limacher, M ;
Assaf, AR ;
Bassford, T ;
Beresford, SAA ;
Black, H ;
Bonds, D ;
Brunner, R ;
Brzyski, R ;
Caan, B ;
Chlebowski, R ;
Curb, D ;
Gass, M ;
Hays, J ;
Heiss, G ;
Hendrix, S ;
Howard, BV ;
Hsia, J ;
Hubbell, A ;
Jackson, R ;
Johnson, KC ;
Judd, H ;
Kotchen, JM ;
Kuller, L ;
LaCroix, AZ ;
Lane, D ;
Langer, RD ;
Lasser, N ;
Lewis, CE ;
Manson, J ;
Margolis, K ;
Ockene, J ;
O'Sullivan, MJ ;
Phillips, L ;
Prentice, RL ;
Ritenbaugh, C ;
Robbins, J ;
Rossouw, JE ;
Sarto, G ;
Stefanick, ML ;
Van Horn, L ;
Wactawski-Wende, J ;
Wallace, R ;
Wassertheil-Smoller, S .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (14) :1701-1712
[3]
Bilgrami Irma, 2004, N Z Med J, V117, pU1175
[4]
Hormone therapy prescribing patterns in the United States [J].
Buist, DSM ;
Newton, KM ;
Miglioretti, DL ;
Beverly, K ;
Connelly, MT ;
Andrade, S ;
Hartsfield, CL ;
Wei, FF ;
Chan, KA ;
Kessler, L .
OBSTETRICS AND GYNECOLOGY, 2004, 104 (05) :1042-1050
[5]
Effect of the women's health initiative on women's decisions to discontinue postmenopausal hormone therapy [J].
Ettinger, B ;
Grady, D ;
Tosteson, ANA ;
Pressman, A ;
Macer, JL .
OBSTETRICS AND GYNECOLOGY, 2003, 102 (06) :1225-1232
[6]
Farquhar CM, 2002, J REPROD MED, V47, P897
[7]
National use of postmenopausal hormone therapy - Annual trends and response to recent evidence [J].
Hersh, AL ;
Stefanick, ML ;
Stafford, RS .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (01) :47-53
[8]
Use of hormone replacement therapy by postmenopausal women in the United States [J].
Keating, NL ;
Cleary, PD ;
Rossi, AS ;
Zaslavsky, AM ;
Ayanian, JZ .
ANNALS OF INTERNAL MEDICINE, 1999, 130 (07) :545-553
[9]
Changes in use of hormone replacement therapy after the report from the Women's Health Initiative: cross sectional survey of users [J].
Lawton, B ;
Rose, S ;
McLeod, D ;
Dowell, A .
BRITISH MEDICAL JOURNAL, 2003, 327 (7419) :845-846
[10]
Use of hormone replacement therapy in the Hong Kong public health sector after the Women's Health Initiative trial [J].
Leung, KY ;
Ling, M ;
Tang, GWK .
MATURITAS, 2005, 52 (3-4) :277-285